We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current AGTX market cap is 7.09M. The company's latest EPS is USD -0.0146 and P/E is -12.33.
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1,000 | 0 | 0 | 0 |
| Operating Income | -344k | -1.34M | -2.29M | -1.37M | -745k |
| Net Income | -364k | -1.34M | -2.29M | -1.37M | -585k |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 293k | 51k | 16k | 261k | 106k |
| Total Liabilities | 69k | 607k | 1.09M | 2.51M | 2.67M |
| Total Equity | 224k | -556k | -1.08M | -2.25M | -2.56M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -369k | -421k | -1,000 | -89k | -110k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 612k | 180k | N/A | 100k | 93k |
| Market Cap | 7.09M |
| Price to Earnings Ratio | -12.33 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.8k |
| Price to Book Ratio | -2.82 |
| Dividend Yield | - |
| Shares Outstanding | 40.07M |
| Average Volume (1 week) | 16.11k |
| Average Volume (1 Month) | 12.91k |
| 52 Week Change | 261.17% |
| 52 Week High | 0.46 |
| 52 Week Low | 0.021 |
| Spread (Intraday) | 0.19 (52.78%) |
| Company Name | Agentix Corporation (PK) |
| Address |
112 north curry street carson city, nevada 89703 4934 |
| Website | https://www.agentixcorp.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
